Skip to content
Lower risk Drug recall · FDA · Published November 23, 2022

Heritage Pharmaceuticals Desmopressin Tablets 0.2mg Recall: Subpotent Drug Risk

Heritage Pharmaceuticals recalls 0.2mg Desmop: Subpotent drug may not work as intended. Rx-only tablets with specific lot number and expiration date. Contact for remedy.

🇺🇸 FDA recall #D-0072-2023DrugHeritage Pharmaceuticals ›
Take action

Contact the company

Recalling firmHeritage Pharmaceuticals Inc1 Tower Center Blvd Ste 1700 · East Brunswick, NJ 08816-1145
✎ GovInfoNow plain-language explainer

Heritage Pharmaceuticals is recalling 0.2mg Desmopressin Acetate Tablets (100-count) due to subpotent drug levels. This means the medication may not work as intended when used as prescribed, potentially affecting treatment effectiveness. Read more at govinfonow.com/recall/34215-heritage-pharmaceuticals-desmopressin-tablets-0-2mg-recall-subpotent-drug-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/34215-heritage-pharmaceuticals-desmopressin-tablets-0-2mg-recall-subpotent-drug-risk · Updated August 18, 2026 · FDA enforcement record: FDA #D-0072-2023

Cite this page

“Heritage Pharmaceuticals Desmopressin Tablets 0.2mg Recall: Subpotent Drug Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34215-heritage-pharmaceuticals-desmopressin-tablets-0-2mg-recall-subpotent-drug-risk. Based on FDA recall #D-0072-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0072-2023%22&limit=1).

Heritage Pharmaceuticals Inc voluntarily recalled Desmopressin Acetate Tablets 0.2mg due to subpotent drug risks, according to the FDA on November 23, 2022. The Food and Drug Administration announced the Class II recall of 13,805 bottles distributed nationwide.

How to tell if you have it

  • Brand: Heritage Pharmaceuticals
  • Product: Desmopressin Acetate Tablets 0.2mg
  • Package: 100-count bottles
  • Distributor: Avet Pharmaceuticals Inc., East Brunswick, NJ
  • NDC: 23155-490-01
  • Lot #: 220440A
  • Expiration Date: 05/2024
  • Quantity: 13,805 bottles

The hazard

The recall addresses the hazard of subpotent drug, meaning the medication may not contain the expected strength of the active ingredient. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Heritage Pharmaceuticals Inc has 11 other recalls on record since February 25, 2015. Other recent recalls include a July 30, 2026, Clindamycin Oral Solution recall for foreign particles and an October 6, 2025, Desipramine Tablets recall for N-Nitroso impurity risk. Similar product recalls in the sector include a July 13, 2026, Levothyroxine Tablets recall by Major Pharmaceuticals, an April 13, 2026, busPIRone Tablets recall by Unichem, and a May 29, 2026, Isopropyl Alcohol 70% recall by Gasco.

How to tell if you have this one

Check for the 100-count bottle labeled 'Desmopressin Acetate Tablets 0.2mg', manufactured by Heritage Pharmaceuticals with lot number 220440A and expiration date 05/2024.

  • Brand
    Heritage Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Medication Details

    Verify the product label includes the lot number 220440A and expiration date 05/2024.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 13 months after the firm started it.

1. Firm started the recall: Nov 23, 202212. FDA classified it Class II: Nov 29, 202223. Published in FDA’s Enforcement Report: Dec 7, 202234. FDA terminated the recall: Dec 13, 2023420222023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Heritage Pharmaceuticals recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0072-2023 (November 23, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0072-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA